β-Blockers and Progression of Coronary Atherosclerosis

  1. Ilke Sipahi, MD; and
  2. Steven E. Nissen, MD
  1. From the Cleveland Clinic, Cleveland, OH 44195.

    IN RESPONSE:

    Dr. Dunaway's statement that “[p]rospective studies have shown no decreased incidence of myocardial infarction (MI) and stroke in patients treated with β-blockers versus placebo” is not true. The meta-analyses by Lindholm and colleagues (1) and Bradley and colleagues (2), involving more than 20 000 patients with hypertension, showed that β-blockers statistically …

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement